CDMO News
Chemical industry CDMO (contract development and manufacturing organization) news
EuroAPI Revision and FOCUS-27 Plan: Divestment of Facilities in Brindisi, Italy and Haverhill, UK in 2027
- WACKER & CordenPharma Prepare for Pandemic Readiness on June 1, 2024 Following Successful Expansion and Qualification in Halle, Germany
- Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany
- WACKER Opens mRNA Competence Center in Halle an der Saale, Germany
- Pantherna and WACKER Strengthen Collaboration for mRNA Biopharmaceutical Development and Production in Halle, Germany
- PanTera signs agreement with Bayer for actinium-225 supply from Mol, Belgium location
CDMO projects
A map of CDMO projects that are planned or currently being executed.
Use chemXplore Analytics to power your research into CDMO.
Scheduled completion
This chart shows how many CDMO projects in the European chemical industry are expected to be completed in the upcoming years.
- Novo Nordisk to invest €2.1bn in expanding manufacturing facilities in Hillerød, Denmark
- WACKER strengthens its biotechnology business with the acquisition of ADL Biopharma in Leon, Spain
- Lonza Finishes Manufacturing Line for Clinical and Commercial Drug Products in Visp (CH)
- Sandoz to Construct New Biologics Production Plant in Lendava, Slovenia, to Meet Growing Global Demand for Biosimilar Medicines
- Expansion of Conjugation Facility in Visp, Switzerland Successfully Completed by Lonza
- Lonza Plans to Build a Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
- Arxada Plans CHF 20m Investment in Industrial Biotechnology Plant in Kouřim, Czech Republic
- Eurofins Increases Chemistry Capacity to Meet Growing Customer Demand in Drug Discovery Market
- Investment by WACKER in Amsterdam Biotech Site
- Expansion of AGC's Spanish Synthetic Pharmaceutical Production Base
- Investment in Multi-Purpose Plant for Allessa by WeylChem Group
- WuXi Vaccines Plans $240 Million Manufacturing Facility in Ireland
- Major Investments in Dessau BioPharmaPark by Merz and Oncotec
- Expansion of Manufacturing Capacity for Biotech Medicines Receives Investment from Merck
- Cerbios expands its manufacturing capacity for high potency APIs through additional investments
- Continuous Technology Drives Almac Group's Progress
- Investment by WACKER in Jena Biotech Site, Germany
- AGC Biologics Increases Capacity at Facility in Copenhagen, Denmark
- Centerpiece for global launches: Ingelheim's new tablet production facility
- Boehringer Ingelheim plans to invest 65 million euros in avian vaccines.
- Saltigo marks 50 years of groundbreaking chemistry
- Expansion of production site in Portugal by Fresenius Kabi
